Indeed, we reported that the expression levels of CD133 mRNA were dramatically restored by the treatment of glioma cell lines with the demethylating agent 5-azacytidine and/or histone deacetylase inhibitor valproic acid [24]. This evidence concerns the gene PROM1 and central nervous system cancer.